Last reviewed · How we verify
Jose J Zaragoza, MD MSc — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Furosemide (Diuretic) | Furosemide (Diuretic) | marketed | Loop diuretic | Na-K-2Cl cotransporter (NKCC2) | Cardiovascular |
Therapeutic area mix
- Cardiovascular · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- B&A Therapeutics · 1 shared drug class
- China National Center for Cardiovascular Diseases · 1 shared drug class
- Ferrer Internacional S.A. · 1 shared drug class
- Heart Care Foundation · 1 shared drug class
- Instituto de Investigación Sanitaria Aragón · 1 shared drug class
- Lakeland Regional Health Systems, Inc. · 1 shared drug class
- Aspirus Heart and Vascular Institute-Research and Education · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Jose J Zaragoza, MD MSc:
- Jose J Zaragoza, MD MSc pipeline updates — RSS
- Jose J Zaragoza, MD MSc pipeline updates — Atom
- Jose J Zaragoza, MD MSc pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Jose J Zaragoza, MD MSc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jose-j-zaragoza-md-msc. Accessed 2026-05-16.